Evidence-based assessment of pregnancy outcome after sumatriptan exposure. - Wikidata - wikimedia - TriplyDB

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

http://www.wikidata.org/entity/Q43989452

about

EFNS guideline on the drug treatment of migraine - report of an EFNS task force Italian guidelines for primary headaches: 2012 revised version Safety of triptans for migraine headaches during pregnancy and breastfeeding.Major malformations after first trimester exposure to aspirin and NSAIDs.Headache in pregnancy: a nuisance or a new sense?Exposure to rizatriptan during pregnancy: post-marketing experience up to 30 June 2004.Migraine headaches and preeclampsia: an epidemiologic review.Triptans in pregnancy.An update in the treatment of neurologic disorders during pregnancy--focus on migraines and seizures.Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis.Ongoing Pharmacological Management of Chronic Pain in Pregnancy.Migraine therapy:seamlessness between plant-derived and synthetic drugs.Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure.Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure.Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.Delivery outcome after maternal use of drugs for migraine: a register study in Sweden.Headache and pregnancy: a systematic review.

P2860

Q28219436-91BD387D-DC7A-4F5D-83FB-EB8D454FA95E Q30466790-2314E41C-EF9D-4842-8143-8B98058E3109 Q33989015-8940057C-AF22-4DEE-95E7-FF46B39CA6E0 Q35085118-35270310-F451-403C-AF58-8E58E4EC804A Q35837966-B15E152C-0988-4B64-AFFA-D091590516DD Q36234257-9161B8ED-6282-4025-92E7-F7BE262C5591 Q36462139-FE8CCA59-BC29-4F6D-B374-08BF20AE02E3 Q36817033-407BF8BF-72B5-4780-9E74-5A2CEF39A0B3 Q38006916-375110EA-6190-4EFC-83AF-77480D70E89C Q38341496-A4A8AF04-7401-4077-BFA2-8E0A6F2CD99E Q38827847-D5D8CDBE-CC96-4A2C-9F4E-D4F09D3010FE Q40493226-ACE66A35-BC4D-4791-A6A3-0C9681CDB9FC Q44794058-DB7ECA25-FA5B-4887-A156-1EE46F08457B Q45031681-21110CC2-1446-4589-A811-A5D0DB11AC40 Q46004711-7E40EFED-7B9C-4DAB-9A09-B54FB88D3034 Q46226323-5D9F8555-40F1-463A-8609-6F4256884FDF Q47146399-8E582D22-DE17-4B89-8A33-FEA1F31478D7

P2860

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

http://www.wikidata.org/entity/Q43989452

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

@en

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

@nl

type

label

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

@en

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

@nl

prefLabel

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

@en

Evidence-based assessment of pregnancy outcome after sumatriptan exposure.

@nl

P1433

Q43989452-ECFD355D-2D02-4BFD-BBAA-F6B0013AA7ED

P1476

Q43989452-AB9265BE-ED0A-4606-81E5-5B198F2302CA

P2093

Q43989452-213A38C8-E4BB-4B98-B43C-B3C5A5E869AC

Q43989452-2833AF96-8453-49AD-AE36-8B801D5172C2

Q43989452-599F3FA9-3995-4D78-9179-A3C4C3ABE5DC

Q43989452-C7C85A29-D4BC-4859-AAE0-2FC47E7E8501

P2860

Q43989452-1EF46746-96E5-4FAE-A1E9-62B9F816B56B

Q43989452-3D90308D-976A-4C74-A921-4A24F1EAF8C9

Q43989452-475B89B9-CC1A-47E0-9C05-F73F39529E74

Q43989452-47BB460A-2DEF-46AA-82A2-1E0414EFB204

Q43989452-5B0315B9-C05B-49E4-8F67-24AD8DD7BFD2

Q43989452-6C9381F8-1175-4B25-87DA-1B63E7662CA4

Q43989452-76598120-32DF-4DA5-B30A-245FDC869E83

Q43989452-8280D3CB-7EE8-4C9C-A032-68C0ADC9D5FF

Q43989452-88F0949D-894C-4284-9E18-FB83EC590499

Q43989452-8B054BA6-7846-4409-984A-9282B15FA38E

P304

Q43989452-5D5161F3-0404-4D47-ACE6-667F1F1B36FE

P31

Q43989452-901B79F2-4CD3-4DEE-A9D5-F91553D7C804

P356

Q43989452-416F7F5B-C658-433D-B6AC-F0C9FEF60754

P433

Q43989452-85FD17DA-170A-45BB-8282-C81C2C0D952A

P478

Q43989452-73430A46-33D6-4F89-8949-A039BA564F6F

P50

Q43989452-1902CF81-51F6-4F30-8321-C0943447F996

P577

Q43989452-1869A617-E6C8-4962-9DD1-92BF26308998

P698

Q43989452-D18D61A1-0339-41C1-B3AB-66F5853F7EAF

P356

J.1526-4610.2002.02007.X

P1433

P1476

Evidence-based assessment of pregnancy outcome after sumatriptan exposure

@en

P2093

Anthony W Fox

http://www.w3.org/2001/XMLSchema#string

Egilius L H Spierings

http://www.w3.org/2001/XMLSchema#string

Merle L Diamond

http://www.w3.org/2001/XMLSchema#string

Philip O Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

Postpartum cerebral angiopathy associated with the administration of sumatriptan and dihydroergotamine--a case report

Migraine in pregnancy: what are the safest treatment options?

Mycotoxins and reproduction in domestic livestock.

Review article: migraine and pregnancy.

The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study.

Teratogen update: ergot and ergotamine.

Large-scale randomized evidence: large, simple trials and overviews of trials.

Headaches and women: treatment of the pregnant and lactating migraineur.

Ergotamine-induced fetal stress: review of side effects of ergot alkaloids during pregnancy.

Embryonic and fetal development: fundamental research.

P304

8-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1526-4610.2002.02007.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Christina D Chambers

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12005279

http://www.w3.org/2001/XMLSchema#string